The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory proposing a collaborative approach to resolving global health issues and improve productivity of drug development. The Core Model proposes that scientific collaboration in society does not occur in an "unstructured" manner, but actually takes place within a highly structured order through which knowledge is transferred, integrated, and finally translated into commercial products for the benefit of society. The way in which this is accomplished is via such avenues as an exchange of information, knowledge, experimental results, and personal connections among collaborating parties. This trading of assets among collaborators is the driving force of innovation and, if done correctly, could save time, labor, and economic resources when developing a new drug. The understanding of this model and its application, by the private and public sectors, could help us solve the global pharmaceutical industry´s productivity problems and address important global health care and economic issues, such as having affordable access to high-quality innovative drugs. This book is useful to researchers, advanced students, regulators and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.